https://doi.org/10.18093/0869-0189-2012-0-3-79-86
- Р Р‡.МессенРТвЂВВВВВВВВжер
- РћРТвЂВВВВВВВВнокласснРСвЂВВВВВВВВРєРСвЂВВВВВВВВ
- LiveJournal
- Telegram
- ВКонтакте
- РЎРєРѕРїРСвЂВВВВВВВВровать ссылку
Full Text:
About the Authors
S. A. KrasovskyRussian Federation
A. V. Chernyak
Russian Federation
E. L. Amelina
Russian Federation
V. S. Nikonova
Russian Federation
A. Yu. Voronkova
Russian Federation
V. A. Samoilenko
Russian Federation
Zh. K. Naumenko
Russian Federation
N. Yu. Kashirskaya
Russian Federation
N. I. Kapranov
Russian Federation
V. D. Sheman
Russian Federation
L. A. Shabalova
Russian Federation
V. P. Chistyakova
Russian Federation
O. I. Simonova
Russian Federation
S. Yu. Semykin
Russian Federation
Yu. V. Gorinova
Russian Federation
L. V. Avakyan
Russian Federation
P. N. Vetrova
Russian Federation
Z. A. Kusova
Russian Federation
M. V. Usacheva
Russian Federation
M. V. Samsonova
Russian Federation
A. L. Chernyaev
Russian Federation
A. G. Chuchalin
Russian Federation
References
1. Cystic Fibrosis Foundation, Patient Registry 2010 Annual Report, Cystic Fibrosis Foundation, Bethesda, Md, USA, 2011. www.cff.org
2. UK CF Registry. Annual data report 2009. Cystic Fibrosis Trust 2011. www.cftrust.org.uk.
3. Canadian Cystic Fibrosis Patient Data Registry Report 2009. www.cysticfibrosis.ca
4. Dodge J.A., Lewis P.A., Stanton M. et al. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur. Respir. J. 2007; 29: 522-526.
5. Amelina E.L., Chernyak A.V., Chernyaev A.L. Mukovistsidoz: opredelenie prodolzhitel'nosti zhizni. Pul'monologiya 2001; 3: 61-64.
6. Chermenskii A.G., Gembitskaya T.E., Orlov A.V. Dinamika vyzhivaemosti bol'nykh mukovistsidozom Sankt-Peterburga za 2000-2008 gg. V kn: Kapranov N.I., Kashirskaya N.Yu. (red.). Materialy IX Natsional'nogo kongressa po mukovistsidozu "Mukovistsidoz u detei i vzroslykh-2009" Mosk. obl. 4-5 apr. 2009 g. M.; 2009. 85-86.
7. Pyaterkina O.G., Shagiakhmetova D.S., Khramova L.V. i dr. Osobennosti techeniya mukovistsidoza v respublike Tatarstan. V kn.: Kapranov N.I., Kashirskaya N.Yu. (red.). Materialy X Yubileinogo Nats. kongressa po mukovistsidozu "Mukovistsidoz u detei i vzroslykh - 2011". Yaroslavl', 1-2 iyunya 2011 g. Yaroslavl'; 2011. 66-67.
8. Chepurnaya M.M., Yagubyants E.T., Belan G.P. Mukovistsidoz detei: osobennosti vedeniya bol'nykh, izuchenie prodolzhitel'nosti zhizni, mediany vyzhivaemosti v Rostovskom regional'nom tsentre. V kn.: Kapranov N.I., Kashirskaya N.Yu. (red.). Materialy IX Natsional'nogo kongressa po mukovistsidozu. "Mukovistsidoz u detei i vzroslykh - 2009". Mosk. obl., 4-5 aprelya 2009 g., M.; 2009. 81-85.
9. Chikunov V.V. Sovershenstvovanie diagnostiki i dispansernogo nablyudeniya bol'nykh mukovistsidozom v Krasnoyarskom krae: Avtoref. dis. ... kand. med. nauk. Krasnoyarsk; 2008.
10. Asherova I.K., Tarakanova V.V., Ganicheva N.P. i dr. 15-letnii opyt raboty tsentra mukovistsidoza v Yaroslavle. V kn.: VIII Natsional'nyi kongress "Mukovistsidoz u detei i vzroslykh". Sbornik statei i tezisov. Yaroslavl', 5-6 iyunya 2007 g. Yaroslavl'; 2007. 28-35.
11. Romanenko N.I., Kondyurina E.G. Izuchenie prodolzhitel'nosti zhizni u bol'nykh mukovistsidozom, prozhivayushchikh v g. Novosibirske. V kn.: VIII Natsional'nyi kongress "Mukovistsidoz u detei i vzroslykh". Sbornik statei i tezisov. Yaroslavl', 5-6 iyunya 2007 g. 132-133.
12. Devaikina M.E. Dinamika vyzhivaemosti i sostoyanie kachestva zhizni bol'nykh mukovistsidozom pod vliyaniem terapevticheskikh kompleksov i sistemy dispansernogo nablyudeniya: Avtoref. dis. … kand. med. nauk. Ekaterinburg; 2003.
13. Krasovskii S.A., Petrova N.V., Nikonova V.S. i dr. Spektr mutatsii gena transmembrannogo regulyatora mukovistsidoza (SFTR) sredi bol'nykh Moskvy i Moskovskoi oblasti. V kn.: Sbornik materialov XIV Kongressa pediatrov Rossii s mezhdunarodnym uchastiem "Aktual'nye problemy pediatrii". Moskva, 24-27 fevr. 2012 g. M.; 384.
14. Voronkova A.Yu., Shmarina G.V., Dubovik L.G. i dr. Dornaza al'fa: klinicheskie i laboratornye effekty. Pul'monologiya 2006; pril. po mukovistsidozu: 25-29.
15. Shah P.L., Convey S.P., Scott S.F. et al. A case controlled study with Dornase Alfa to evaluate impact on disease progression over a 4 year period. Respiration 2001; 68: 160-164.
16. Ramsey B.W., Astley S.J., Aitken M.L. et al. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am. Rev.Respir. Dis. 1993; 148 (1): 145-151.
17. Nodson M.E. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis. Am. J. Respir. Crit. Care Med. 1995; 151: S70-S74.
18. Fuchs H.J., Borowitz D.S., Christiansen D.H. et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N. Engl. J. Med. 1994; 331: 637-642.
Review
For citations:
Krasovsky S.A., Chernyak A.V., Amelina E.L., Nikonova V.S., Voronkova A.Yu., Samoilenko V.A., Naumenko Zh.K., Kashirskaya N.Yu., Kapranov N.I., Sheman V.D., Shabalova L.A., Chistyakova V.P., Simonova O.I., Semykin S.Yu., Gorinova Yu.V., Avakyan L.V., Vetrova P.N., Kusova Z.A., Usacheva M.V., Samsonova M.V., Chernyaev A.L., Chuchalin A.G. . PULMONOLOGIYA. 2012;(3):79-86. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-3-79-86
ISSN 2541-9617 (Online)